A new oral GLP-1 drug, aleniglipron, showed significant weight loss of up to 12.1% in a 36-week trial, offering a potential alternative to injectable medications.
A study using zebrafish found that an existing osteoporosis drug could prevent spinal damage, offering a new path for treating back pain.
A study in zebrafish found that an existing osteoporosis drug blocked spinal damage, offering new hope for treating intervertebral disc degeneration and back pain.
An experimental antiviral pill prevented a measles-like virus from spreading through air and contact in ferrets, offering a new tool against outbreaks.
A new "Trojan horse" drug for obesity and type two diabetes shows promise in mouse studies, delivering a metabolic enhancer directly to cells for improved weight loss and blood sugar control.